---  
layout: startup_page  
title: "Human Immunology Biosciences (HI-Bio)"  
id: "hibio.com"  
permalink: "/humanimmunologybioscienceshibiohibio.com01042024/"  
website: "https://hibio.com/"  
funding_round: "Series B"  
funding_amount: "$95M"  
investors: "Alpha Wave Global, Viking Global Investors, Arkin Bio Capital, Jeito Capital, ARCH Venture Partners"  
about: "Human Immunology Biosciences (HI-Bio) is a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs). Their lead candidate, felzartamab, targets CD38 and is being advanced through clinical trials for multiple indications. HI-Bio also has a pipeline of other candidates targeting cellular drivers of disease."  
markets: "Biotechnology, Immunotherapy, Life Science, Medical, Product Research, Therapeutics"  
hq: "South San Francisco, California, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/hibio"  
twitter: "https://twitter.com/HIBiosciences"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/human-immunology-biosciences"  
pitchbook: "https://pitchbook.com/profiles/company/498391-30"  

date_display: "04-Jan-2024"  
date: "2024-01-04"

# SEO Optimization  
meta_title: "Human Immunology Biosciences (HI-Bio) - Series B Funding ($95M)"  
meta_description: "Human Immunology Biosciences (HI-Bio), Human Immunology Biosciences (HI-Bio) is a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated..."  
meta_keywords: "Human Immunology Biosciences (HI-Bio), Biotechnology, Immunotherapy, Life Science, Medical, Product Research, Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/humanimmunologybioscienceshibiohibio.com01042024/"  
---